glp 1 black friday deals JoinFridays™️ Telehealth (@joinfridays) • Threads, Say more GLP-1 costs rise, but there

Tirzepatide, the first dual GIP/GLP-1 receptor co-agonist approved for type 2 diabetes in the USA, Europe, and the UAE, targets both appetite and glucose control

Other oral compounds like CT-996 / RG 6652 showed a clinically meaningful weight reduction of 6-7% in four weeks among participants without T2D, and GSBR-1290 has demonstrated favourable safety, tolerability and efficacy results

analysis of treatment plans, including compounded GLP-1s, customers taking a compounded GLP-1 reported losing an average of 20.9 pounds or 10.3% of initial body weight, within six months, while reporting a low rate of side effects

GLP-1s are a class of medications originally approved for type 2 diabetes management that have seen dramatic growth in prescribing following expanded approvals for chronic weight management

What does the Eli Lilly compounding lawsuit dismissal mean for the GLP-1 market